Aa
A
A
Close
Avatar universal
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
Source

Institute of Virology, Technische Universität München / Helmholtz
Zentrum München, Trogerstrasse, 30, 81675 Munich, Germany.

Abstract

Current treatment of chronic Hepatitis B virus (HBV) infection mainly
targets viral replication in hepatocytes and leads to curing only in
exceptional cases. Despite their potential to improve therapeutic
success, no drugs interfering with early infection steps of the
hepatotropic pathogen HBV are available to date. Recently, entry of the
Hepatitis C virus (HCV) has been shown to occur along hepatic
cholesterol uptake pathways and ezetimibe, a drug which blocks this
lipid transport, has been shown to inhibit HCV infection. We here
investigated the effect of ezetimibe on HBV infection using
differentiated HepaRG-cells as a cell-culture infection model. Treatment
with ezetimibe inhibited establishment of intrahepatic cccDNA and
expression of viral replication markers when cells were infected with
HBV virions, while we observed no effect when the HBV viral genome was
transduced via an adenoviral vector. Our data suggest that modulating
hepatic cholesterol uptake by ezetimibe inhibits early HBV infection and
that ezetimibe sensitive lipid transport pathways represent new targets
for antiviral therapy in HBV infection.
Cancel
5 Answers
Page 1 of 1
Avatar universal
did anybody ever try this cholesterol drug on tdf or etv therapy?

although this is in vitro we can check ourself if reinfection under nnucs is blocked or lowered and if any effect on hbsag
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal

do you think it worths a try on antivirals therapy or antivirals plus interferon since this drug has pratically no sides?

http://archive.mail-list.com/hbv_research/message/20121227.011814.a4604094.en.html

Ezetimibe blocks hepatitis B virus infection after virus uptake into
hepatocytes.

We here investigated the effect of ezetimibe on HBV infection using
differentiated HepaRG-cells as a cell-culture infection model. Treatment
with ezetimibe inhibited establishment of intrahepatic cccDNA and
expression of viral replication markers when cells were infected with
HBV virions, while we observed no effect when the HBV viral genome was
transduced via an adenoviral vector. Our data suggest that modulating
hepatic cholesterol uptake by ezetimibe inhibits early HBV infection and
that ezetimibe sensitive lipid transport pathways represent new targets
for antiviral therapy in HBV infection.

Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
According to Wikipedia, Ezetimibe has side effect - "it increased the thickness of artery walls and caused more major cardiovascular events"
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal

that s probably a study on patients already sick with cardiovascular events and arteries.it is like tenofovir story with kidneys, studies on hiv patient are not relevant to hbv patients

we just have to look for effect on cccdna/hbsag if any and refer to studies on healthy subjects for sides effects, not studies on sick patients
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
http://www.sciencedirect.com/science/article/pii/S0166354212002884

here s the link to the abstract with som e charts, full article is not free
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Your Answer
Avatar universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources
RSS Expert Activity
233488 tn?1310696703
Blank
Marathon Running Done Over Many Yea...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
233488 tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
05/15 by John C Hagan III, MD, FACS, FAAOBlank
748543 tn?1463449675
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
Avatar m tn
Blank
stef2011
Italy
Avatar m tn
Blank
Aduiski
Other
Avatar m tn
Blank
StephenCastlecrag
Australia
Avatar m tn
Blank
sorte
Poland
Avatar m tn
Blank
Ram1982
Bangalore, India
Avatar m tn
Blank
Jatashankar
India